Drug:
Reaction: DRUG HYPERSENSITIVITY
20250101 - 20251231
No. 1001 - 1100
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
1001 | 24968445 |
AU |
65 | 2 |
Pneumonia, Drug hypersensitivity, Influenza like illness, Abdominal pain lower, Flatulence, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, |
||||
1002 | 24968452 |
US |
2 | |
Drug hypersensitivity, |
||||
AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, AMOXICILLIN AND CLAVULANATE POTASSIUM, CEFDINIR, CHOLESTYRAMINE, ERYTHROMYCIN, GABAPENTIN, PREGABALIN, |
||||
1003 | 24968586 |
CA |
37 | 2 |
Concussion, Dizziness, Drug hypersensitivity, Dyspnoea, Food allergy, Gait disturbance, Head injury, Headache, Hypoaesthesia, Limb injury, Lip pruritus, Middle insomnia, Migraine, Mobility decreased, Nausea, Pain, Pain in extremity, Pruritus, Tongue pruritus, Urticaria, Off label use, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, EPINEPHRINE, LORAZEPAM, NAPROXEN, MONTELUKAST SODIUM, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, ALBUTEROL SULFATE, UBROGEPANT, |
||||
1004 | 24969004 |
US |
1 | |
Drug hypersensitivity, Underdose, |
||||
1005 | 24969380 |
CA |
62 | 2 |
Asthma, Chills, Cough, Dizziness, Drug hypersensitivity, Dyspnoea exertional, Forced expiratory volume decreased, Frequent bowel movements, Headache, Infection, Joint dislocation, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, SENNOSIDES, CICLESONIDE, CICLESONIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, MONTELUKAST SODIUM, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, |
||||
1006 | 24969644 |
CA |
76 | 1 |
Bladder discomfort, Drug hypersensitivity, Inappropriate schedule of product administration, Hot flush, Urinary tract infection, Asthma, Blood pressure increased, Chest pain, |
||||
MONTELUKAST, OMALIZUMAB, PENICILLIN G BENZATHINE, ALBUTEROL SULFATE, BUDESONIDE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, PREDNISONE, TIOTROPIUM BROMIDE, |
||||
1007 | 24969651 |
CA |
44 | 2 |
Anxiety, Arthropod bite, Barrett^s oesophagus, Blood pressure decreased, Body temperature increased, Chest pain, Dizziness, Drug hypersensitivity, Dysphagia, Dyspnoea, Ear swelling, Eye swelling, Fatigue, Feeling hot, Haemorrhage, Headache, Heart rate increased, Hyperhidrosis, Hypoaesthesia, Hypotension, Illness, Incorrect dose administered, Insomnia, Laryngitis, Middle insomnia, Nasopharyngitis, Oropharyngeal pain, Pain, Palpitations, Panic reaction, Papule, Paraesthesia, Peripheral swelling, Pneumonia, Pruritus, Pulmonary embolism, Rash, Rash erythematous, Scratch, Sensitivity to weather change, Skin lesion, Skin mass, Skin plaque, Swelling, Swollen tongue, Throat tightness, Urinary tract infection, Urticaria, Weight increased, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CYCLOSPORINE, APIXABAN, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CYCLOBENZAPRINE, APIXABAN, EPINEPHRINE, FAMOTIDINE, FERROUS SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYZINE, LANSOPRAZOLE, LANSOPRAZOLE, MONTELUKAST, PANTOPRAZOLE, PREGABALIN, MONTELUKAST SODIUM, |
||||
1008 | 24969859 |
TH |
||
Drug hypersensitivity, Arrhythmia, Syncope, Cardiotoxicity, Pulmonary mass, Hypotension, Lung disorder, Bedridden, |
||||
OSIMERTINIB, OSIMERTINIB, |
||||
1009 | 24970102 |
TN |
65 | 2 |
Drug hypersensitivity, Rash, Azotaemia, Blood creatinine increased, |
||||
ERTAPENEM, ERTAPENEM SODIUM, ALLOPURINOL, |
||||
1010 | 24970276 |
CA |
68 | 2 |
Drug hypersensitivity, Confusional state, |
||||
1011 | 24970285 |
CA |
84 | 1 |
Deep vein thrombosis, Device related thrombosis, Drug hypersensitivity, Eosinophilia, Pulmonary embolism, Rash, Thrombocytopenia, |
||||
CEFADROXIL, CEFAZOLIN SODIUM, CEFAZOLIN, ATROPINE SULFATE, ATROPINE, |
||||
1012 | 24970388 |
US |
||
Drug hypersensitivity, |
||||
BAYER ASPIRIN EXTRA STRENGTH, |
||||
1013 | 24970498 |
GB |
25 | 2 |
Drug hypersensitivity, |
||||
DOXYCYCLINE, DOXYCYCLINE HYCLATE, HYDROXOCOBALAMIN, |
||||
1014 | 24970690 |
US |
1 | |
Eyelid ptosis, Drug hypersensitivity, Adverse drug reaction, |
||||
ONABOTULINUMTOXINA, |
||||
1015 | 24970699 |
US |
52 | 2 |
Nasal inflammation, Nasal pruritus, Product prescribing issue, Drug hypersensitivity, Rhinalgia, |
||||
1016 | 24970928 |
DE |
17 | 1 |
Intestinal operation, Rash macular, Skin disorder, Acne, Drug ineffective, Puncture site erythema, Drug hypersensitivity, |
||||
ADALIMUMAB, ADALIMUMAB, RISANKIZUMAB-RZAA, UPADACITINIB, |
||||
1017 | 24970986 |
US |
73 | 2 |
Drug hypersensitivity, Swelling of eyelid, Rash, Hordeolum, Eye infection, Skin exfoliation, Pruritus, Foreign body sensation in eyes, Erythema, Dry skin, Therapeutic product effect delayed, Eye irritation, Vasodilatation, Eye swelling, Ocular discomfort, Eyelid irritation, |
||||
TOBRAMYCIN AND DEXAMETHASONE, TOBRAMYCIN AND DEXAMETHASONE, |
||||
1018 | 24971343 |
US |
69 | 1 |
Drug hypersensitivity, |
||||
ETANERCEPT, |
||||
1019 | 24971398 |
CA |
40 | 2 |
Synovitis, Taste disorder, Vomiting, Weight increased, Wound, Drug hypersensitivity, Drug intolerance, Product use issue, Product quality issue, Intentional product use issue, Contraindicated product administered, Product use in unapproved indication, Treatment failure, Therapeutic product effect decreased, Therapeutic product effect incomplete, Drug ineffective, Wheezing, Musculoskeletal stiffness, Malaise, Insomnia, Hepatitis, Headache, Gastrointestinal disorder, Finger deformity, Fall, Dyspepsia, Condition aggravated, Coeliac disease, Adverse reaction, Abdominal distension, Grip strength decreased, Product label confusion, Alopecia, Abdominal discomfort, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Blood cholesterol increased, Drug-induced liver injury, Fatigue, Exposure during pregnancy, General physical health deterioration, Glossodynia, Hepatic enzyme increased, Hand deformity, Hypersensitivity, Hypertension, Off label use, |
||||
CELECOXIB, CELECOXIB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, SECUKINUMAB, SECUKINUMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, OXYCODONE, RAMIPRIL, PANTOPRAZOLE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ERENUMAB-AOOE, CANDESARTAN, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, GOLIMUMAB, TRETINOIN, TOFACITINIB, VITAMIN C, PHENYLEPHRINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE, ERGOCALCIFEROL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, APREMILAST, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE, AZATHIOPRINE SODIUM, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, DESOXIMETASONE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLD, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, |
||||
1020 | 24971937 |
DE |
2 | |
Psoriatic arthropathy, Head discomfort, Pain, Visual impairment, Eye swelling, Swelling face, Blood thyroid stimulating hormone increased, Drug hypersensitivity, |
||||
LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM, |
||||
1021 | 24972307 |
US |
77 | 2 |
Drug hypersensitivity, |
||||
THALIDOMIDE, |
||||
1022 | 24980258 |
46 | 2 | |
Haemodialysis, Malaise, Flushing, Dyspnoea, Back pain, Dysphonia, Blood pressure increased, Heart rate increased, Drug hypersensitivity, Therapy cessation, |
||||
METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA, |
||||
1023 | 24962948 |
US |
76 | 1 |
Drug hypersensitivity, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
1024 | 24963450 |
US |
23 | 2 |
Drug ineffective, Horner^s syndrome, Drug hypersensitivity, |
||||
CLONIDINE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, POVIDONE-IODINE, POVIDONE IODINE, 10% POVIDONE-IODINE, BUPIVACAINE, BUPIVACAINE HYDROCHLORIDE IN DEXTROSE, IVABRADINE, |
||||
1025 | 24963476 |
US |
1 | |
Myalgia, Drug hypersensitivity, |
||||
OMAVELOXOLONE, GABAPENTIN, |
||||
1026 | 24963675 |
ES |
47 | 2 |
Drug hypersensitivity, |
||||
OCRELIZUMAB, |
||||
1027 | 24963710 |
US |
50 | 2 |
Drug hypersensitivity, Intestinal angioedema, |
||||
LISINOPRIL, MESALAMINE, AZATHIOPRINE, |
||||
1028 | 24963877 |
US |
72 | 2 |
Drug hypersensitivity, Pulmonary thrombosis, Drug hypersensitivity, Haemolytic anaemia, Rash, |
||||
RITUXIMAB, OBINUTUZUMAB, ALLOPURINOL, MEPERIDINE HYDROCHLORIDE, |
||||
1029 | 24963909 |
US |
53 | 2 |
Skin exfoliation, Swelling face, Psoriasis, Drug hypersensitivity, |
||||
ADALIMUMAB, |
||||
1030 | 24964103 |
CA |
67 | 2 |
Abdominal pain, Alanine aminotransferase increased, Alopecia, Arthralgia, Arthritis, Arthropathy, Aspartate aminotransferase increased, Basal cell carcinoma, Blood parathyroid hormone decreased, Breath sounds abnormal, C-reactive protein abnormal, C-reactive protein increased, Condition aggravated, Dermatitis, Drug eruption, Drug hypersensitivity, Drug intolerance, Drug tolerance, Erythema, Fatigue, Gastrointestinal disorder, Granuloma skin, Headache, Hepatic enzyme increased, Hepatitis, Hypercalcaemia, Hypersensitivity, Hypertension, Inflammation, Infusion related reaction, Insomnia, Joint swelling, Loss of personal independence in daily activities, Musculoskeletal stiffness, Nausea, Neoplasm skin, Off label use, Pain, Panniculitis, Peripheral swelling, Pneumonia, Prescribed underdose, Pruritus, Pulmonary fibrosis, Rash, Rash pruritic, Red blood cell sedimentation rate increased, Rheumatoid arthritis, Rheumatoid factor positive, Rheumatoid nodule, Skin necrosis, Skin neoplasm excision, Skin ulcer, Synovitis, Therapeutic product effect decreased, Ulcer, Vomiting, |
||||
RITUXIMAB, RITUXIMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, |
||||
1031 | 24964531 |
CA |
50 | 1 |
Arthropathy, Bone cancer, Contusion, Drug hypersensitivity, Ligament sprain, Lip and/or oral cavity cancer, Lung neoplasm malignant, Malaise, Nasopharyngitis, Respiratory syncytial virus infection, Vital functions abnormal, Weight decreased, Inappropriate schedule of product administration, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, LEVOTHYROXINE, HYDROXYCHLOROQUINE SULFATE, METHOTREXATE, METHOTREXATE SODIUM, DICLOFENAC, DICLOFENAC SODIUM, |
||||
1032 | 24965079 |
US |
57 | 1 |
Drug hypersensitivity, |
||||
LINEZOLID, |
||||
1033 | 24965154 |
US |
32 | 2 |
Rash maculo-papular, Drug hypersensitivity, Condition aggravated, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE, CAPECITABINE, |
||||
1034 | 24965279 |
US |
62 | 1 |
Drug hypersensitivity, |
||||
APREMILAST, |
||||
1035 | 24965286 |
CA |
||
C-reactive protein abnormal, C-reactive protein increased, Confusional state, Drug hypersensitivity, Dyspnoea, Ill-defined disorder, Infusion related reaction, Injection site reaction, Nausea, Onychomadesis, Onychomycosis, Pain, Pemphigus, Pericarditis, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid arthritis, Sleep disorder, Swelling, Synovitis, Wound, Type 2 diabetes mellitus, Systemic lupus erythematosus, Therapeutic product effect decreased, Therapeutic product effect incomplete, Treatment failure, Drug ineffective, Underdose, Overdose, Contraindicated product administered, Product use issue, Product use in unapproved indication, Intentional product use issue, Intentional product use issue, Intentional product use issue, Off label use, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ERENUMAB-AOOE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, APREMILAST, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, AZATHIOPRINE SODIUM, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CANDESARTAN, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERGOCALCIFEROL, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLIMUMAB, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE SODIUM SUCCINATE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LAMOTRIGINE, LAMOTRIGINE, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, DIATRIZOATE MEGLUMINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MINOCYCLINE, MINOCYCLINE, MIRABEGRON, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NEOMYCIN SULFATE, MEPOLIZUMAB, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, OXYCODONE, POVIDONE-IODINE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RAMIPRIL, RAMIPRIL, RAMIPRIL, RANITIDINE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RETINOL, ASCORBIC ACID, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, DESOGESTREL AND ETHINYL ESTRADIOL, |
||||
1036 | 24965593 |
NL |
68 | 2 |
Drug hypersensitivity, Drug ineffective, |
||||
CYCLOSPORINE, MEPOLIZUMAB, ANAKINRA, |
||||
1037 | 24965854 |
CA |
40 | 2 |
Abdominal discomfort, Abdominal distension, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, Coeliac disease, Condition aggravated, Confusional state, Contraindicated product administered, Depression, Diarrhoea, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Drug-induced liver injury, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Epilepsy, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypertension, Ill-defined disorder, Impaired healing, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Intentional product use issue, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver function test increased, Liver injury, Loss of personal independence in daily activities, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Obesity, Onychomadesis, Onychomycosis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Product label confusion, Product quality issue, Product use in unapproved indication, Psoriatic arthropathy, Rash, Rheumatic fever, Sleep disorder, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Therapeutic product effect decreased, Treatment failure, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, |
||||
1038 | 24966540 |
CA |
50 | 2 |
Asthenia, COVID-19 immunisation, Disturbance in attention, Dizziness, Fatigue, Feeling cold, Immunisation reaction, Memory impairment, Menstrual disorder, Mental impairment, Nervousness, Pallor, Product preparation issue, Tooth infection, Toothache, Chest pain, Drug hypersensitivity, Vaccination complication, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, AMLODIPINE, TRAMADOL HYDROCHLORIDE, CALCIUM CARBONATE, ANTACID, GABAPENTIN, EMPAGLIFLOZIN, MELATONIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, NORTRIPTYLINE HYDROCHLORIDE, OLANZAPINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OXYBUTYNIN CHLORIDE, SEMAGLUTIDE, SERTRALINE HYDROCHLORIDE, LEVOTHYROXINE SODIUM, ERGOCALCIFEROL, CALCIUM SENNOSIDES, |
||||
1039 | 24966753 |
US |
83 | 2 |
Drug hypersensitivity, |
||||
ETANERCEPT, METHOTREXATE SODIUM, |
||||
1040 | 24966758 |
US |
74 | 2 |
Drug hypersensitivity, |
||||
LINEZOLID, |
||||
1041 | 24966998 |
US |
||
Drug hypersensitivity, |
||||
ELOSULFASE ALFA, EPINEPHRINE, ADRENALINUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, LORAZEPAM, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, METHYLPREDNISOLONE SODIUM SUCCINATE, |
||||
1042 | 24967286 |
CA |
56 | 2 |
Dizziness, Malaise, Somnolence, Weight decreased, Ear swelling, Urticaria, Swelling face, Skin plaque, Skin hypertrophy, Insomnia, Injection site pain, Quality of life decreased, Fatigue, Drug hypersensitivity, Scab, Wrong technique in product usage process, Panic disorder, Feeling abnormal, Skin haemorrhage, Papule, Ill-defined disorder, Depression, Scratch, Swelling, Diarrhoea, Balance disorder, Rash macular, |
||||
MORPHINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, |
||||
1043 | 24969565 |
78 | 2 | |
Drug hypersensitivity, Injection site urticaria, Therapy cessation, |
||||
DUPILUMAB, |
||||
1044 | 24970247 |
80 | 1 | |
Infusion related reaction, Head discomfort, Pruritus, Flushing, Dialysis, Drug hypersensitivity, |
||||
VANCOMYCIN HYDROCHLORIDE, |
||||
1045 | 24971336 |
24 | 1 | |
Urticaria, Drug hypersensitivity, |
||||
EXTENDED PHENYTOIN SODIUM, EXTENDED PHENYTOIN SODIUM, |
||||
1046 | 24971338 |
60 | 2 | |
Abdominal pain lower, Micturition urgency, Type I hypersensitivity, Drug hypersensitivity, Diarrhoea, Vision blurred, |
||||
CEFTRIAXONE, CEFTRIAXONE SODIUM, CEFTRIAXONE, CEFTRIAXONE SODIUM, |
||||
1047 | 24957999 |
US |
1 | |
Drug hypersensitivity, |
||||
EZETIMIBE, |
||||
1048 | 24958294 |
US |
67 | 2 |
Injection site urticaria, Drug hypersensitivity, Drug hypersensitivity, Injection site erythema, Injection site papule, Injection site pruritus, Off label use, |
||||
ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, MEPERIDINE HYDROCHLORIDE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, |
||||
1049 | 24958492 |
US |
39 | 2 |
Drug hypersensitivity, Dyspnoea, Palpitations, |
||||
METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA, |
||||
1050 | 24958776 |
US |
||
Ocular hyperaemia, Condition aggravated, Lacrimation increased, Periorbital swelling, Drug hypersensitivity, |
||||
NETARSUDIL, |
||||
1051 | 24958814 |
US |
2 | |
Drug hypersensitivity, Palpitations, Diarrhoea, |
||||
LINEZOLID, PENICILLIN G SODIUM, |
||||
1052 | 24959060 |
PT |
53 | 2 |
Hypersensitivity, Drug hypersensitivity, Product dose omission issue, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, |
||||
1053 | 24959097 |
CA |
33 | 2 |
Asthma, COVID-19, Cardiac disorder, Drug hypersensitivity, Dyspnoea, Fatigue, Foot fracture, Gait inability, Headache, Ligament sprain, Migraine, Myalgia, |
||||
OMALIZUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE FUROATE, FLUTICASONE FUROATE, COLCHICINE, DEXLANSOPRAZOLE, PREDNISONE, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE, TERBUTALINE SULFATE, LISDEXAMFETAMINE DIMESYLATE, |
||||
1054 | 24959151 |
CA |
2 | |
Abdominal discomfort, Abdominal pain upper, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Back disorder, Blister, Blood cholesterol increased, Breast cancer stage II, Chest pain, Condition aggravated, Confusional state, Contusion, Decreased appetite, Delirium, Depression, Diarrhoea, Disability, Discomfort, Dislocation of vertebra, Drug hypersensitivity, Duodenal ulcer perforation, Dyspepsia, Fatigue, Fibromyalgia, Fluid retention, Folliculitis, Gait disturbance, Gait inability, Gastrointestinal disorder, General physical health deterioration, General symptom, Glossodynia, Grip strength decreased, Hand deformity, Helicobacter infection, Hepatic enzyme increased, Hip arthroplasty, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, Injury, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Knee arthroplasty, Liver injury, Lower respiratory tract infection, Malaise, Memory impairment, Migraine, Muscle injury, Musculoskeletal stiffness, Myositis, Nasopharyngitis, Nausea, Oedema, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Pruritus, Psoriasis, Psoriatic arthropathy, Pulmonary fibrosis, Pustular psoriasis, Pyrexia, Pulmonary fibrosis, Rash, Rash vesicular, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Subcutaneous drug absorption impaired, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Vomiting, Walking aid user, Weight decreased, Weight increased, Wheezing, Wound, Wound infection, X-ray abnormal, |
||||
SARILUMAB, |
||||
1055 | 24959219 |
CA |
44 | 2 |
Abdominal pain upper, Abdominal discomfort, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, Chest pain, Colitis ulcerative, Condition aggravated, Confusional state, Contusion, Decreased appetite, Delirium, Depression, Diarrhoea, Discomfort, Dislocation of vertebra, Dizziness, Drug hypersensitivity, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Facet joint syndrome, Fatigue, Feeling hot, Fibromyalgia, Folliculitis, Frequent bowel movements, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hypersensitivity, Hypertension, Ill-defined disorder, Impaired healing, Infection, Inflammation, Infusion related reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver disorder, Lower respiratory tract infection, Lung disorder, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Nasopharyngitis, Night sweats, Obesity, Oedema, Oedema peripheral, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Porphyria acute, Pruritus, Psoriatic arthropathy, Pyrexia, Rash, Rectal haemorrhage, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Weight decreased, Weight increased, Wheezing, Wound, Wound infection, |
||||
INDOMETHACIN, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, PREDNISONE, PREDNISONE, APREPITANT, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, SULFASALAZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, GOLIMUMAB, ADALIMUMAB, HYDROCORTISONE SODIUM SUCCINATE, HYDROCORTISONE SODIUM SUCCINATE, HYDROCORTISONE SODIUM SUCCINATE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LEFLUNOMIDE, LEFLUNOMIDE, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, SULFASALAZINE, SECUKINUMAB, GOLIMUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, RITUXIMAB-ABBS, RITUXIMAB-ABBS, ERGOCALCIFEROL, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VITAMIN C, FISH OIL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CALCIUM GLUCONATE, ERGOCALCIFEROL, QUETIAPINE FUMARATE, QUETIAPINE, LANSOPRAZOLE, |
||||
1056 | 24959277 |
US |
2 | |
Drug hypersensitivity, |
||||
IVABRADINE, |
||||
1057 | 24959304 |
CA |
32 | 1 |
Acute myocardial infarction, Angina pectoris, Arteriospasm coronary, Drug hypersensitivity, Hypokinesia, Kounis syndrome, Myocardial infarction, Drug ineffective, |
||||
CEFTRIAXONE SODIUM, CEFTRIAXONE SODIUM, DAPTOMYCIN, METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, AMLODIPINE, RIZATRIPTAN, RIZATRIPTAN, |
||||
1058 | 24959463 |
US |
2 | |
Surgery, Anxiety, Muscle spasms, Back pain, Irritable bowel syndrome, Drug hypersensitivity, |
||||
SODIUM OXYBATE, SODIUM OXYBATE, SODIUM OXYBATE, AMOXICILLIN AND CLAVULANATE POTASSIUM, SODIUM OXYBATE, OMALIZUMAB, |
||||
1059 | 24959574 |
US |
1 | |
Drug hypersensitivity, |
||||
HEPARIN SODIUM, |
||||
1060 | 24959785 |
CA |
40 | 2 |
Peripheral swelling, Abdominal discomfort, Abdominal distension, Abdominal pain upper, Adverse reaction, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, C-reactive protein increased, Coeliac disease, Confusional state, Condition aggravated, Contusion, Depression, Diarrhoea, Dizziness, Drug hypersensitivity, Drug-induced liver injury, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Epilepsy, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Hepatic enzyme increased, Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Inflammation, Injection site reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver function test increased, Liver injury, Loss of personal independence in daily activities, Lung disorder, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscle spasms, Muscular weakness, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Obesity, Onychomadesis, Onychomycosis, Osteoarthritis, Pain, Pain in extremity, Live birth, Urticaria, Paraesthesia, Peripheral swelling, Peripheral venous disease, Rheumatic fever, Sleep disorder, Stomatitis, Taste disorder, Infusion related reaction, Underdose, Off label use, Maternal exposure during pregnancy, Treatment failure, Intentional product use issue, Exposure during pregnancy, Drug intolerance, Drug ineffective, Contraindicated product administered, Product quality issue, Therapeutic product effect decreased, Therapeutic product effect incomplete, Lower respiratory tract infection, Helicobacter infection, Decreased appetite, Type 2 diabetes mellitus, Urticaria, Weight increased, Wheezing, Wound infection, |
||||
SARILUMAB, |
||||
1061 | 24959962 |
US |
1 | |
Drug hypersensitivity, |
||||
FINASTERIDE, |
||||
1062 | 24960275 |
US |
1 | |
Drug hypersensitivity, |
||||
FINASTERIDE, |
||||
1063 | 24960276 |
US |
1 | |
Drug hypersensitivity, Lip swelling, Rash, Pruritus, |
||||
FINASTERIDE, |
||||
1064 | 24960486 |
CA |
59 | 2 |
Patella fracture, Tibia fracture, Ulna fracture, Clavicle fracture, Radius fracture, Road traffic accident, Off label use, Drug hypersensitivity, |
||||
RITUXIMAB-PVVR, RITUXIMAB-PVVR, RITUXIMAB-PVVR, RITUXIMAB-PVVR, RITUXIMAB-PVVR, RITUXIMAB-PVVR, RITUXIMAB-PVVR, RITUXIMAB-PVVR, RITUXIMAB-PVVR, RITUXIMAB-PVVR, DULOXETINE HYDROCHLORIDE, DULOXETINE, ATORVASTATIN CALCIUM, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LEVOTHYROXINE SODIUM, |
||||
1065 | 24960972 |
CA |
40 | 2 |
Abdominal discomfort, Abdominal distension, Abdominal pain upper, Adverse reaction, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, C-reactive protein increased, Coeliac disease, Condition aggravated, Confusional state, Contraindicated product administered, Depression, Diarrhoea, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Drug-induced liver injury, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Epilepsy, Exposure during pregnancy, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Intentional product use issue, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Live birth, Liver function test increased, Liver injury, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal pain, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Obesity, Off label use, Onychomadesis, Onychomycosis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid arthritis, Sleep disorder, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Loss of personal independence in daily activities, Product label confusion, Product quality issue, Product use in unapproved indication, Taste disorder, Therapeutic product effect decreased, Treatment failure, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, |
||||
BUPRENORPHINE, OXYCODONE HYDROCHLORIDE, OXYCODONE, TRAMADOL HYDROCHLORIDE, DICLOFENAC, DICLOFENAC SODIUM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, VITAMIN C, TOFACITINIB, TOFACITINIB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ADALIMUMAB, ADALIMUMAB, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, NAPROXEN, NAPROXEN SODIUM, |
||||
1066 | 24961060 |
CA |
50 | 2 |
Abdominal discomfort, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthropathy, Asthenia, Asthma, Autoimmune disorder, Blister, Blood cholesterol increased, Bursitis, C-reactive protein, C-reactive protein abnormal, Chest pain, Condition aggravated, Confusional state, Contraindicated product administered, Contusion, Decreased appetite, Deep vein thrombosis postoperative, Diarrhoea, Discomfort, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Dyspnoea, Fatigue, Fibromyalgia, Folliculitis, Gait inability, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hip arthroplasty, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Inflammation, Infusion related reaction, Injury, Intentional product use issue, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Knee arthroplasty, Lip dry, Liver disorder, Liver injury, Lower limb fracture, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Nasopharyngitis, Nausea, Night sweats, Obesity, Oedema, Off label use, Osteoarthritis, Pain, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pregnancy, Prescribed overdose, Product use in unapproved indication, Product use issue, Pruritus, Psoriatic arthropathy, Pyrexia, Rash, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Road traffic accident, Sciatica, Sinusitis, Sleep disorder due to general medical condition, hypersomnia type, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Swollen joint count, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Tender joint count, Therapeutic product effect decreased, Therapy non-responder, Treatment failure, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, |
||||
SARILUMAB, |
||||
1067 | 24961170 |
DE |
59 | 1 |
Drug hypersensitivity, Blood pressure systolic increased, Erythema, Chest pain, |
||||
DAROLUTAMIDE, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
1068 | 24961172 |
CA |
65 | 2 |
Asthma, Chest pain, Cough, Drug hypersensitivity, Dyspnoea, Malaise, Nasal oedema, Oedema, Pain, Pneumonia, Respiratory tract infection, Vomiting, Wheezing, |
||||
MONTELUKAST SODIUM, MONTELUKAST SODIUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, AMLODIPINE, AMLODIPINE BESYLATE, CALCIUM, CALCIUM CARBONATE, ANTACID, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CIPROFLOXACIN HYDROCHLORIDE, CLONAZEPAM, CLONAZEPAM, ERGOCALCIFEROL, ERGOCALCIFEROL, ERGOCALCIFEROL, FLUTICASONE PROPIONATE, FOLIC ACID, HYDROMORPHONE HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, PREDNISONE, RISEDRONATE SODIUM, RITUXIMAB, ROPIVACAINE HYDROCHLORIDE, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, THEOPHYLLINE, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, CEFADROXIL, CEFADROXIL, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, |
||||
1069 | 24962035 |
US |
62 | 2 |
Drug hypersensitivity, |
||||
LENALIDOMIDE, |
||||
1070 | 24962038 |
US |
62 | 2 |
Drug hypersensitivity, |
||||
LENALIDOMIDE, |
||||
1071 | 24962284 |
US |
82 | 2 |
Drug hypersensitivity, Vomiting, |
||||
METHOTREXATE SODIUM, |
||||
1072 | 24962295 |
US |
2 | |
Pruritus, Drug hypersensitivity, Nipple pain, Product substitution issue, |
||||
ESTRADIOL, |
||||
1073 | 24962419 |
CA |
43 | 2 |
Adjustment disorder with depressed mood, Abdominal discomfort, Abdominal pain, Abdominal pain upper, Adverse drug reaction, Adverse event, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Back disorder, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage II, Breast cancer stage III, Bursitis, C-reactive protein abnormal, C-reactive protein increased, Chest pain, Condition aggravated, Confusional state, Contusion, Decreased appetite, Delirium, Depression, Diarrhoea, Disability, Discomfort, Dislocation of vertebra, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Epilepsy, Facet joint syndrome, Fatigue, Fibromyalgia, Fluid retention, Folliculitis, Gait disturbance, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, General symptom, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hip arthroplasty, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Inflammation, Infusion related reaction, Injury, Intentional product use issue, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Knee arthroplasty, Lip dry, Liver injury, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Myositis, Nail disorder, Nasopharyngitis, Nausea, Night sweats, Obesity, Oedema, Oedema peripheral, Off label use, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Product quality issue, Product use in unapproved indication, Pruritus, Psoriasis, Psoriatic arthropathy, Pulmonary fibrosis, Pustular psoriasis, Pyrexia, Rash, Rash vesicular, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Sleep disorder, Sleep disorder due to a general medical condition, Stomatitis, Subcutaneous drug absorption impaired, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Vomiting, Walking aid user, Weight decreased, Weight increased, Wheezing, Wound infection, Wound, X-ray abnormal, Sinusitis, Bone erosion, Deep vein thrombosis postoperative, No adverse event, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, BUPRENORPHINE, TRAMADOL HYDROCHLORIDE, ACETAMINOPHEN AND CODEINE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, GOLD, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LAMOTRIGINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, MEPOLIZUMAB, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, APREMILAST, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RANITIDINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, CALCIUM CARBONATE, USTEKINUMAB, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, BOTULINUM TOXIN TYPE A, CANDESARTAN, CELECOXIB, CELECOXIB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, VEDOLIZUMAB, NAPROXEN, NAPROXEN SODIUM, ERENUMAB-AOOE, ATOMOXETINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, SECUKINUMAB, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, PHENYLEPHRINE HYDROCHLORIDE, APREMILAST, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, LORAZEPAM, CALCIUM, CALCIUM, CALCIUM, CAFFEINE CITRATE, CYANOCOBALAMIN, ERGOCALCIFEROL, ASIAN GINSENG, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LISINOPRIL, LANSOPRAZOLE, LORAZEPAM, NICOTINAMIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, LANSOPRAZOLE, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, RISEDRONATE SODIUM, THIAMINE HYDROCHLORIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VITAMIN A, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, ERGOCALCIFEROL, LISINOPRIL, FISH OIL, SULFASALAZINE, |
||||
1074 | 24962510 |
US |
62 | 2 |
Drug hypersensitivity, |
||||
SARILUMAB, |
||||
1075 | 24962711 |
CA |
65 | 2 |
Asthma, Drug hypersensitivity, Dyspnoea, Oedema, Pneumonia, Vomiting, Wheezing, |
||||
CLONAZEPAM, OMALIZUMAB, RITUXIMAB, PREDNISONE, MONTELUKAST, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMLODIPINE BESYLATE, FLUTICASONE PROPIONATE, HYDROMORPHONE HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, RISEDRONATE SODIUM, ROPIVACAINE HYDROCHLORIDE, ROSUVASTATIN CALCIUM, TRAMADOL HYDROCHLORIDE, |
||||
1076 | 24962734 |
US |
||
Reaction to preservatives, Eye pain, Drug hypersensitivity, |
||||
PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
1077 | 24965422 |
58 | 2 | |
Joint swelling, Swollen tongue, Oedema peripheral, Oedema peripheral, Facial pain, Swelling, Stomatitis, Aphasia, Drug hypersensitivity, Tongue dry, Oral disorder, Muscle spasms, |
||||
TIRZEPATIDE, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, |
||||
1078 | 24952722 |
CN |
67 | |
Flushing, Pruritus, Rash, Induration, Erythema, Peripheral swelling, Swelling face, Drug hypersensitivity, |
||||
ROSUVASTATIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLOPIDOGREL, CLOPIDOGREL BISULFATE, |
||||
1079 | 24952755 |
US |
23 | 2 |
Drug hypersensitivity, Injection site urticaria, Injection site swelling, Injection site rash, Urinary tract infection, Dyspnoea, |
||||
DUPILUMAB, |
||||
1080 | 24952964 |
US |
2 | |
Drug hypersensitivity, Vomiting, Nausea, |
||||
FUROSEMIDE, PAZOPANIB HYDROCHLORIDE, PAZOPANIB HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, |
||||
1081 | 24953285 |
US |
79 | 1 |
Drug hypersensitivity, Dyspnoea, Pruritus, Blood pressure diastolic decreased, Flushing, Drug hypersensitivity, |
||||
METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA, IRON SUCROSE, |
||||
1082 | 24953385 |
CA |
40 | 2 |
Abdominal discomfort, Abdominal distension, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, C-reactive protein increased, Coeliac disease, Condition aggravated, Confusional state, Depression, Diarrhoea, Dizziness, Drug hypersensitivity, Drug-induced liver injury, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Epilepsy, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Impaired healing, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Live birth, Liver function test increased, Liver injury, Loss of personal independence in daily activities, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Normal newborn, Obesity, Onychomadesis, Onychomycosis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid arthritis, Sleep disorder, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, |
||||
SARILUMAB, |
||||
1083 | 24953420 |
US |
2 | |
Drug hypersensitivity, Diarrhoea, Weight decreased, Rash, Nausea, Vomiting, |
||||
AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, ERYTHROMYCIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, NILOTINIB, NILOTINIB, NILOTINIB, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, |
||||
1084 | 24953421 |
CA |
54 | 1 |
Abdominal hernia, Asthma, Blood pressure increased, Blood urine present, Chest pain, Chronic pigmented purpura, Decreased activity, Diverticulitis, Drug hypersensitivity, Dyspnoea, Fatigue, Gastroenteritis, Headache, Hiatus hernia, Illness, Infection, Influenza, Inguinal hernia, Middle insomnia, Paraesthesia, Pharyngitis, Pneumonia, Productive cough, Pyrexia, Sinonasal obstruction, Sinus polyp, Sputum discoloured, Subcutaneous abscess, Tachycardia, Thyroid mass, Wheezing, Incorrect dose administered, Wrong technique in product usage process, Inappropriate schedule of product administration, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CARBAMAZEPINE, CARBAMAZEPINE, VALSARTAN, ARIPIPRAZOLE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, CICLESONIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, LORATADINE, LORATADINE TABLET, IRON, MOMETASONE FUROATE, MOMETASONE, MONTELUKAST, MOXIFLOXACIN HYDROCHLORIDE, NAPROXEN, OXAZEPAM, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, ALBUTEROL SULFATE, ALBUTEROL, SILDENAFIL CITRATE, SILDENAFIL, SULFASALAZINE, TERBUTALINE SULFATE, TOPIRAMATE, TOPIRAMATE SPINKLE, ALBUTEROL SULFATE, AZITHROMYCIN DIHYDRATE, |
||||
1085 | 24953490 |
IT |
61 | 1 |
Drug hypersensitivity, Face oedema, Erythema, |
||||
1086 | 24953549 |
JP |
||
Drug hypersensitivity, |
||||
DURVALUMAB, CARBOPLATIN, |
||||
1087 | 24953586 |
CA |
97 | 2 |
Abdominal discomfort, Abdominal pain upper, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Back disorder, Blister, Blood cholesterol increased, Breast cancer stage II, Chest pain, Condition aggravated, Confusional state, Contusion, Decreased appetite, Delirium, Depression, Diarrhoea, Discomfort, Dislocation of vertebra, Drug hypersensitivity, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Fatigue, Fibromyalgia, Fluid retention, Folliculitis, Gait disturbance, Gait inability, Gastrointestinal disorder, General physical health deterioration, General symptom, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, Injury, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Liver injury, Lower respiratory tract infection, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Musculoskeletal stiffness, Myositis, Nasopharyngitis, Nausea, Oedema, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Pruritus, Psoriasis, Psoriatic arthropathy, Pulmonary fibrosis, Pustular psoriasis, Pyrexia, Rash, Rash vesicular, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Subcutaneous drug absorption impaired, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight decreased, Weight increased, Wheezing, Wound, Wound infection, X-ray abnormal, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, |
||||
1088 | 24954169 |
DE |
60 | 1 |
Rash, Drug hypersensitivity, Xerophthalmia, Peripheral sensory neuropathy, Infection, Dry mouth, Erythema, Fatigue, Constipation, Diarrhoea, Pyrexia, Stomatitis, |
||||
OXALIPLATIN, FLUOROURACIL, NIVOLUMAB, NIVOLUMAB, NIVOLUMAB, NIVOLUMAB, NIVOLUMAB, NIVOLUMAB, NIVOLUMAB, NIVOLUMAB, NIVOLUMAB, PALONOSETRON, PALONOSETRON HYDROCHLORIDE, MIRTAZAPINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, LEUCOVORIN CALCIUM, APREPITANT, ALITRETINOIN, AMPHOTERICIN B, |
||||
1089 | 24954201 |
CA |
53 | 2 |
Abscess oral, Fatigue, Erythema, Discomfort, Arthralgia, Wheezing, Body temperature decreased, Sneezing, Skin papilloma, Fungal infection, Nasal congestion, Spirometry abnormal, Tooth abscess, Muscular weakness, Cellulitis, Tachycardia, Oropharyngeal pain, Pain, Rhinorrhoea, Vitamin D deficiency, Drug hypersensitivity, Wrong technique in product usage process, Nausea, Gingival pain, Choking, Dyspnoea, Contusion, Hypersensitivity, Cough, Hyperkeratosis, Chest discomfort, Arrhythmia, Asthma, |
||||
NAPROXEN, NAPROXEN SODIUM, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, CICLESONIDE, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, MOMETASONE FUROATE, TIOTROPIUM BROMIDE, MONTELUKAST, LANSOPRAZOLE, |
||||
1090 | 24954237 |
US |
1 | |
Dehydration, Foot fracture, Drug hypersensitivity, Localised infection, Erythema, Oropharyngeal pain, Nasopharyngitis, Dental caries, Product dose omission issue, Hereditary angioedema, |
||||
ICATIBANT ACETATE, ICATIBANT ACETATE, ECALLANTIDE, OXYBUTYNIN CHLORIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
1091 | 24954464 |
US |
1 | |
Drug hypersensitivity, Skin exfoliation, |
||||
ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, |
||||
1092 | 24954531 |
US |
35 | 2 |
Treatment noncompliance, Drug hypersensitivity, Product use in unapproved indication, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, RISPERIDONE, CLONAZEPAM, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, HALOPERIDOL, HALOPERIDOL LACTATE, LITHIUM, LITHIUM BROMATUM, |
||||
1093 | 24955087 |
US |
65 | 2 |
Drug hypersensitivity, |
||||
METHOTREXATE SODIUM, |
||||
1094 | 24955215 |
US |
2 | |
Drug intolerance, Adverse drug reaction, Drug hypersensitivity, Rash, Off label use, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, CAPECITABINE, TUCATINIB, |
||||
1095 | 24955370 |
US |
||
Drug hypersensitivity, |
||||
RUXOLITINIB, MOMELOTINIB, |
||||
1096 | 24955539 |
CA |
22 | 2 |
Migraine, Nausea, Neutrophil count, Polyarthritis, Rheumatoid arthritis, Weight decreased, Weight increased, Anaphylactic reaction, Injection site pain, Drug hypersensitivity, Leukopenia, Treatment failure, Therapy partial responder, Drug ineffective, |
||||
SARILUMAB, TOCILIZUMAB, BELIMUMAB, INFLIXIMAB, NAPROXEN, NAPROXEN SODIUM, RITUXIMAB, LEFLUNOMIDE, CANDESARTAN, CELECOXIB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, LANSOPRAZOLE, GOLIMUMAB, GOLIMUMAB, LEVOTHYROXINE SODIUM, |
||||
1097 | 24955540 |
|||
Drug hypersensitivity, |
||||
INSULIN LISPRO, |
||||
1098 | 24956052 |
|||
Drug hypersensitivity, Inappropriate schedule of product administration, |
||||
MEPOLIZUMAB, LISINOPRIL, |
||||
1099 | 24956087 |
IT |
68 | 2 |
Dysaesthesia pharynx, Dyspnoea, Erythema, Drug hypersensitivity, |
||||
OXALIPLATIN, |
||||
1100 | 24956094 |
ZA |
38 | 2 |
Joint injury, Drug hypersensitivity, Impaired healing, Wound infection, |
||||
ADALIMUMAB, METHOTREXATE, METHOTREXATE SODIUM, |
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28